News|Slideshows|August 24, 2024

Now Trending: US Birth Rate at Record Low, WHO Declares Mpox Emergency

Check out this recap of articles published on our sister sites during the past week.

Explore articles from the past week published on Drug Topics’ sister brands AJMC, Formulary Watch, and Managed Healthcare Executive. From mixed reactions toward the CMS-negotiated drug prices to new COVID-19 vaccine approvals, read up on recent health care industry news.

Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Related to this article

PCAC, FDA Peptide Hearing, Compounded Peptides, 503A Compounding

September 25th, 2026

Pharmacy Law Lowdown: FDA’s Evaluation of Peptides

This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.

September 25th, 2026

Early CGMs Results in Better 5-Year Glucose Control in Type 1 Diabetes

A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.

Postmenopausal Women, GLP-1 Therapy, Muscle Loss, Sarcopenia

September 25th, 2026

Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women

With obesity, muscle loss, and sleep disorders so prominent in postmenopause, providers are now looking into further expansion of GLP-1 use.

September 25th, 2026

Menopause Status, Symptoms Remain Inconsistently Documented

Menopause status and symptoms are inconsistently captured in electronic health records, leaving a gap in care for patients.

Main Street Pharmacy Access Act, Pharmacist Provider Status, Test-and-Treat Services, Medicare Part B, Social Security Act

September 24th, 2026

The Legislation Setting the Stage for Pharmacy’s Next Leap

As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.

September 24th, 2026

Study Finds Reduced Cardiovascular Risk With Hormone Therapy Initiation

Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.